logggologggologggo
  • Home
  • Our Company
    • About QuanDx
  • Products
    • Leukemia
      • Leukemia Fusion Genes (Q30) Screening Kit
      • Leukemia FusionOne Panel Kit
      • Leukemia Q-Fusion BCR-ABL1 Genotyping and Quantification Kits
      • Leukemia Q-Fusion PML-RARα Genotyping and Quantification Kits
    • Infectious Diseases
      • MeltPro High Risk HPV Genotyping Assay
  • Press
    • News
    • Events
  • Customer Endorsements
  • Technology
    • Yin-Yang-Probes
    • Melting Curve Analysis
  • Contact Us
  • Distributors
0
  • The Latest Information

  • The Latest Information

QuanDx Announces Distribution Agreement for the Zeesan CE-IVD High Risk HPV Genotyping Assay
November 24, 2015
QuanDx Raises $3.0 Million in Series B2 Financing
January 11, 2016
23

See you at AMP annual meeting in Austin, TX

San Francisco, CA, USA. Sept. 24th, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, welcome you to stop by our Booth (#215) in Austin, TX.

Recent News

  • 0
    GenomeWeb Reports a feature story on QuanDx HPV testing by Dartmouth research group led by Dr. Tsongalis
    May 31, 2019
  • 0
    QuanDx/Zeesan Biotech’s MeltPro High Risk HPV Genotyping Assay is Effective for Cervical Cancer Screening for Women in Low- and Middle-Income Countries
    May 28, 2019
  • 0
    AMP 2019 Annual Meeting
    May 28, 2019
  • 0
    AMP 2016 Annual Meeting
    July 14, 2016
  • 0
    ASM/ICAAC, 2016
    June 16, 2016
footer_logo1
  • Sitemap
  • Privacy Policy
  • Terms of Use

© QuanDx. All Rights reserved.

Quick Links

  • Investor and Media
  • Current Job Opportunities
  • Contact Us

Contact Us

Toll Free in US
1-855-782-6392
1-855-QuanDx-Care

info@quandx.com

Stay Connected

© 2025 QuanDx. All Rights Reserved. Muffin group
    ×
    Item Added to your Cart!
    There are no products
    Continue Shopping